遂宁盛新最近一期经审计的资产负债率低于70%，公司本次为遂宁盛新提供1.5亿元的担保额度后，资 产负债率低于70%的子公司的可用担保额度为70.2亿元。截至本公告日，公司对遂宁盛新的担保总额 （不含本次担保）为117,095.26万元。本次担保事项在公司2024年年度股东大会授权范围内，符合《深 圳证券交易所股票上市规则》和《公司章程》等相关规定。 二、被担保人基本情况 登录新浪财经APP 搜索【信披】查看更多考评等级 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 一、担保情况概述 盛新锂能集团股份有限公司（以下简称"公司"）全资子公司遂宁盛新锂业有限公司（以下简称"遂宁盛 新"）因业务发展需要，拟与信达金融租赁股份有限公司（以下简称"信达金租"）开展融资租赁业务， 融资租赁本金为人民币1.5亿元，融资租赁期限为36个月。2025年11月14日，公司与信达金租签署了 《不可撤销的保证函》，为上述融资事项提供连带责任保证。 公司分别于2025年3月21日、2025年4月11日召开第八届董事会第十八次会议和2024年年度股东大会，审 议通过了《关于对下属子公司提 ...

Group 1 - The stock price of Sinochem International (600500) closed at 4.41 yuan on November 14, 2025, an increase of 1.61% from the previous week [1] - The highest intraday price reached 4.52 yuan on November 14, while the lowest was 4.34 yuan on November 10 [1] - The current total market capitalization of Sinochem International is 15.825 billion yuan, ranking 20th out of 170 in the chemical products sector and 1209th out of 5165 in the A-share market [1] Group 2 - Sinochem International's 2019 restricted stock incentive plan has met the conditions for the third unlock period, with 55 individuals eligible for the release of 1,583,550 shares, accounting for 0.044% of the total share capital [1] - The released shares will be available for trading starting November 18, 2025 [1] - The company has achieved its performance assessment targets for the year 2022, allowing the incentive recipients to meet the conditions for the release of shares [1] Group 3 - Sinochem International will hold a third-quarter earnings presentation on November 20, 2025, from 15:00 to 16:00 via the Shanghai Stock Exchange Roadshow Center [2] - Participants in the meeting will include the company's chairman, independent directors, CFO, and board secretary [2] - Investors can submit questions from November 13 to November 19, 2025, through the Shanghai Stock Exchange Roadshow Center website or the company's email [2]

Core Viewpoint - Haike Xinyuan has entered a "surge period" since late September, with its stock price experiencing significant volatility and an increase of over 100% in just eight trading days [1][3]. Group 1: Stock Performance - On November 13, Haike Xinyuan achieved a "20cm" limit-up, closing at 69.22 CNY per share with a turnover rate of 32.53% and a trading volume of 276,700 shares [1]. - The stock price continued to rise on November 14, reaching a historical high of 80.03 CNY during the day and closing at 72.7 CNY, up 5.03% [1]. - The company had been in a prolonged state of decline since its IPO in July 2023, where it was listed at an issue price of 19.99 CNY per share [3]. Group 2: Financial Performance - In 2024, Haike Xinyuan reported a revenue of 3.615 billion CNY, a year-on-year increase of 7.49%, but a net profit attributable to shareholders of -267 million CNY, a decline of 944.35% [6]. - The decline in profitability is attributed to intense price competition in the lithium-ion battery electrolyte solvent market, a decrease in product sales prices and gross margins, and high fixed costs due to low production load at a new facility [6]. - For the first three quarters of the year, the company reported a revenue of 3.653 billion CNY, a year-on-year increase of 43.17%, and a net profit of -128 million CNY, a reduction in losses by 40.06% [7]. Group 3: Market Position and Outlook - Haike Xinyuan is recognized as a global leader in lithium battery solvents, with a stable competitive position and an improving industry supply-demand dynamic [7]. - The company is also developing its additives segment, which is beginning to gain traction, with potential for significant profit elasticity due to rising prices in this area [7].

Key Points - 华盛锂电's production and operations have not undergone significant changes, but the company faces risks of performance decline or losses due to uncertainties in the downstream lithium battery industry and ongoing cost reduction efforts [4] - 莎普爱思 has received approval for clinical trials of a drug aimed at maintaining dilation during cataract surgery, which may enhance its product offerings in the ophthalmology sector [5] - 奥比中光 has completed over 10 chip tape-outs, including iToF and dToF sensing chips, indicating strong progress in its chip development for 3D vision technology [6][7] - 利欧股份 has provided a joint liability guarantee of 420 million yuan for its wholly-owned subsidiary, indicating financial support amidst the subsidiary's reported losses [8] - 瀚川智能's controlling shareholder is facing judicial auction of 2.67% of its shares, which could impact the company's ownership structure [9] - 天汽模 is planning a cash acquisition of 50% of 东实股份, which would make it a controlling subsidiary, although the transaction is still in the planning stage [10] - 我武生物 has decided to terminate the development of a specific drug project, indicating a strategic shift in its R&D focus [11] - 航天机电's subsidiary has won an arbitration case for nearly 191.71 billion Korean won, which may have implications for the company's financials [12] - 长源电力's subsidiary has received approval for a 100MW wind power project, reflecting ongoing investments in renewable energy [13] Performance Overview - 天马科技 reported a total eel output of approximately 1732.99 tons in October 2025, with a sales price range of 55,000 to 100,000 yuan per ton [14] - 中国建筑 signed new contracts worth 3.61 trillion yuan in the first ten months of 2025, showing a year-on-year growth of 1% [15] - 赣粤高速's vehicle toll service revenue for October 2025 was 266 million yuan [16] - 中国中冶's new contract amount for the first ten months of 2025 was 845.07 billion yuan, a year-on-year decrease of 11.8% [17] - 中煤能源's coal sales in October 2025 were 21.88 million tons, a year-on-year decrease of 12.8% [18] - 上海机场's Pudong International Airport passenger throughput increased by 12.46% year-on-year in October 2025 [19] - 中国神华's coal production in October 2025 was 26.4 million tons, a year-on-year decrease of 7.4% [20] Shareholding Changes - 骆驼股份's chairman plans to reduce his stake by up to 0.6137% due to personal financial needs [21] - 清源股份's controlling shareholder has reduced its holdings of convertible bonds by 13.71% [22] - 永兴股份's shareholder plans to reduce its stake by up to 1% due to funding needs [23]

Core Viewpoint - Fuxiang Pharmaceutical (300497) announced plans to increase its production capacity for VC and FEC products, indicating a strategic response to market demand and industry capacity release [1] Group 1: Production Capacity - The company currently has a production capacity of 8,000 tons per year for VC products and approximately 4,000 tons per year for FEC products [1] - Plans are in place to enhance VC production capacity to 10,000 tons per year, with the upgrade expected to be completed by the second quarter of 2026 [1] - Future capacity expansions may increase VC production to 20,000 tons per year and FEC production to 5,000 tons per year, depending on market demand and industry conditions [1] Group 2: Key Customers - Major customers for the company's VC and FEC products include Tianqi Materials (002709) and Xinjubang (300037) [1]

Core Viewpoint - The company emphasizes its commitment to global market expansion, with products exported to regions including the United States, Europe, and Africa [1] Group 1: Market Strategy - The company is focused on emerging markets, particularly in Africa, and is monitoring local infrastructure and real estate developments for market opportunities [1] - The company plans to steadily advance its market expansion efforts while ensuring compliance with local regulations [1] Group 2: Trade Policy Awareness - The company is closely observing international trade policies and tariff adjustments, recognizing that changes in these areas can impact export operations [1] - The company adheres strictly to trade regulations and policies in its export activities to the United States, ensuring orderly business operations [1]

Core Insights - As of the end of October, the number of shareholders for Lier Chemical (002258) reached 42,042 [1] Company Information - Lier Chemical has actively engaged with investors through an interactive platform, indicating a commitment to transparency and communication [1] - The increase in shareholder count may reflect growing investor interest in the company [1]

（文章来源：证券日报） 证券日报网讯万丰股份11月14日在互动平台回答投资者提问时表示，截至2025年11月10日，公司的股东 户数为7841户。 ...

Group 1 - The core viewpoint of the article is that Taihe Technology announced the composition of its R&D team, highlighting that it is led by experts and primarily consists of professionals recruited from academic institutions and trained internally, with most members holding graduate degrees [2] Group 2 - The R&D team is structured under the leadership of an expert group, indicating a focus on high-level guidance and expertise [2] - The recruitment strategy emphasizes hiring from academic institutions, suggesting a commitment to integrating academic knowledge with practical applications [2] - The internal training of team members reflects the company's investment in developing specialized talent tailored to its operational needs [2]

Group 1 - The core viewpoint of the article is that Taihe Technology (300801) is focused on independent research and development without current collaborations with universities on R&D projects, although there are some minor commercial partnerships [1] Group 2 - Taihe Technology confirmed that all its R&D projects are self-developed [1] - The company has not engaged in any R&D collaborations with academic institutions [1] - There are a few commercial partnerships, but they are limited in scope [1]